1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Adeno-Associated Virus Vectors in Gene Therapy Annual Sales 2020-2031 2.1.2 World Current & Future Analysis for Adeno-Associated Virus Vectors in Gene Therapy by Geographic Region, 2020, 2024 & 2031 2.1.3 World Current & Future Analysis for Adeno-Associated Virus Vectors in Gene Therapy by Country/Region, 2020, 2024 & 2031 2.2 Adeno-Associated Virus Vectors in Gene Therapy Segment by Type 2.2.1 Serotype 2 (AVV 2) 2.2.2 Synthetic Serotypes 2.2.3 Others 2.3 Adeno-Associated Virus Vectors in Gene Therapy Sales by Type 2.3.1 Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Type (2020-2025) 2.3.2 Global Adeno-Associated Virus Vectors in Gene Therapy Revenue and Market Share by Type (2020-2025) 2.3.3 Global Adeno-Associated Virus Vectors in Gene Therapy Sale Price by Type (2020-2025) 2.4 Adeno-Associated Virus Vectors in Gene Therapy Segment by Application 2.4.1 Alzheimer's Disease 2.4.2 Cystic Dibrosis 2.4.3 Hemophilia B 2.4.4 Parkinson's Disease 2.5 Adeno-Associated Virus Vectors in Gene Therapy Sales by Application 2.5.1 Global Adeno-Associated Virus Vectors in Gene Therapy Sale Market Share by Application (2020-2025) 2.5.2 Global Adeno-Associated Virus Vectors in Gene Therapy Revenue and Market Share by Application (2020-2025) 2.5.3 Global Adeno-Associated Virus Vectors in Gene Therapy Sale Price by Application (2020-2025) 3 Global by Company 3.1 Global Adeno-Associated Virus Vectors in Gene Therapy Breakdown Data by Company 3.1.1 Global Adeno-Associated Virus Vectors in Gene Therapy Annual Sales by Company (2020-2025) 3.1.2 Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Company (2020-2025) 3.2 Global Adeno-Associated Virus Vectors in Gene Therapy Annual Revenue by Company (2020-2025) 3.2.1 Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Company (2020-2025) 3.2.2 Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Company (2020-2025) 3.3 Global Adeno-Associated Virus Vectors in Gene Therapy Sale Price by Company 3.4 Key Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Product Location Distribution 3.4.2 Players Adeno-Associated Virus Vectors in Gene Therapy Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Adeno-Associated Virus Vectors in Gene Therapy by Geographic Region 4.1 World Historic Adeno-Associated Virus Vectors in Gene Therapy Market Size by Geographic Region (2020-2025) 4.1.1 Global Adeno-Associated Virus Vectors in Gene Therapy Annual Sales by Geographic Region (2020-2025) 4.1.2 Global Adeno-Associated Virus Vectors in Gene Therapy Annual Revenue by Geographic Region (2020-2025) 4.2 World Historic Adeno-Associated Virus Vectors in Gene Therapy Market Size by Country/Region (2020-2025) 4.2.1 Global Adeno-Associated Virus Vectors in Gene Therapy Annual Sales by Country/Region (2020-2025) 4.2.2 Global Adeno-Associated Virus Vectors in Gene Therapy Annual Revenue by Country/Region (2020-2025) 4.3 Americas Adeno-Associated Virus Vectors in Gene Therapy Sales Growth 4.4 APAC Adeno-Associated Virus Vectors in Gene Therapy Sales Growth 4.5 Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Growth 4.6 Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Growth 5 Americas 5.1 Americas Adeno-Associated Virus Vectors in Gene Therapy Sales by Country 5.1.1 Americas Adeno-Associated Virus Vectors in Gene Therapy Sales by Country (2020-2025) 5.1.2 Americas Adeno-Associated Virus Vectors in Gene Therapy Revenue by Country (2020-2025) 5.2 Americas Adeno-Associated Virus Vectors in Gene Therapy Sales by Type (2020-2025) 5.3 Americas Adeno-Associated Virus Vectors in Gene Therapy Sales by Application (2020-2025) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Adeno-Associated Virus Vectors in Gene Therapy Sales by Region 6.1.1 APAC Adeno-Associated Virus Vectors in Gene Therapy Sales by Region (2020-2025) 6.1.2 APAC Adeno-Associated Virus Vectors in Gene Therapy Revenue by Region (2020-2025) 6.2 APAC Adeno-Associated Virus Vectors in Gene Therapy Sales by Type (2020-2025) 6.3 APAC Adeno-Associated Virus Vectors in Gene Therapy Sales by Application (2020-2025) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Adeno-Associated Virus Vectors in Gene Therapy by Country 7.1.1 Europe Adeno-Associated Virus Vectors in Gene Therapy Sales by Country (2020-2025) 7.1.2 Europe Adeno-Associated Virus Vectors in Gene Therapy Revenue by Country (2020-2025) 7.2 Europe Adeno-Associated Virus Vectors in Gene Therapy Sales by Type (2020-2025) 7.3 Europe Adeno-Associated Virus Vectors in Gene Therapy Sales by Application (2020-2025) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy by Country 8.1.1 Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales by Country (2020-2025) 8.1.2 Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Revenue by Country (2020-2025) 8.2 Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales by Type (2020-2025) 8.3 Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales by Application (2020-2025) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Adeno-Associated Virus Vectors in Gene Therapy 10.3 Manufacturing Process Analysis of Adeno-Associated Virus Vectors in Gene Therapy 10.4 Industry Chain Structure of Adeno-Associated Virus Vectors in Gene Therapy 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Adeno-Associated Virus Vectors in Gene Therapy Distributors 11.3 Adeno-Associated Virus Vectors in Gene Therapy Customer 12 World Forecast Review for Adeno-Associated Virus Vectors in Gene Therapy by Geographic Region 12.1 Global Adeno-Associated Virus Vectors in Gene Therapy Market Size Forecast by Region 12.1.1 Global Adeno-Associated Virus Vectors in Gene Therapy Forecast by Region (2026-2031) 12.1.2 Global Adeno-Associated Virus Vectors in Gene Therapy Annual Revenue Forecast by Region (2026-2031) 12.2 Americas Forecast by Country (2026-2031) 12.3 APAC Forecast by Region (2026-2031) 12.4 Europe Forecast by Country (2026-2031) 12.5 Middle East & Africa Forecast by Country (2026-2031) 12.6 Global Adeno-Associated Virus Vectors in Gene Therapy Forecast by Type (2026-2031) 12.7 Global Adeno-Associated Virus Vectors in Gene Therapy Forecast by Application (2026-2031) 13 Key Players Analysis 13.1 Amicus Therapeutics 13.1.1 Amicus Therapeutics Company Information 13.1.2 Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product Portfolios and Specifications 13.1.3 Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2025) 13.1.4 Amicus Therapeutics Main Business Overview 13.1.5 Amicus Therapeutics Latest Developments 13.2 Asklepios Biopharmaceutical 13.2.1 Asklepios Biopharmaceutical Company Information 13.2.2 Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Product Portfolios and Specifications 13.2.3 Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2025) 13.2.4 Asklepios Biopharmaceutical Main Business Overview 13.2.5 Asklepios Biopharmaceutical Latest Developments 13.3 BioMarin Pharmaceutical 13.3.1 BioMarin Pharmaceutical Company Information 13.3.2 BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Product Portfolios and Specifications 13.3.3 BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2025) 13.3.4 BioMarin Pharmaceutical Main Business Overview 13.3.5 BioMarin Pharmaceutical Latest Developments 13.4 Coave Therapeutics 13.4.1 Coave Therapeutics Company Information 13.4.2 Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product Portfolios and Specifications 13.4.3 Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2025) 13.4.4 Coave Therapeutics Main Business Overview 13.4.5 Coave Therapeutics Latest Developments 13.5 MeiraGTx 13.5.1 MeiraGTx Company Information 13.5.2 MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Product Portfolios and Specifications 13.5.3 MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2025) 13.5.4 MeiraGTx Main Business Overview 13.5.5 MeiraGTx Latest Developments 13.6 Neurocrine Biosciences 13.6.1 Neurocrine Biosciences Company Information 13.6.2 Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Product Portfolios and Specifications 13.6.3 Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2025) 13.6.4 Neurocrine Biosciences Main Business Overview 13.6.5 Neurocrine Biosciences Latest Developments 13.7 Pfizer 13.7.1 Pfizer Company Information 13.7.2 Pfizer Adeno-Associated Virus Vectors in Gene Therapy Product Portfolios and Specifications 13.7.3 Pfizer Adeno-Associated Virus Vectors in Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2025) 13.7.4 Pfizer Main Business Overview 13.7.5 Pfizer Latest Developments 13.8 Roche Holding 13.8.1 Roche Holding Company Information 13.8.2 Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Product Portfolios and Specifications 13.8.3 Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2025) 13.8.4 Roche Holding Main Business Overview 13.8.5 Roche Holding Latest Developments 13.9 Sangamo Therapeutics 13.9.1 Sangamo Therapeutics Company Information 13.9.2 Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product Portfolios and Specifications 13.9.3 Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2025) 13.9.4 Sangamo Therapeutics Main Business Overview 13.9.5 Sangamo Therapeutics Latest Developments 13.10 Sarepta Therapeutics 13.10.1 Sarepta Therapeutics Company Information 13.10.2 Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product Portfolios and Specifications 13.10.3 Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2025) 13.10.4 Sarepta Therapeutics Main Business Overview 13.10.5 Sarepta Therapeutics Latest Developments 13.11 Spark Therapeutics 13.11.1 Spark Therapeutics Company Information 13.11.2 Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product Portfolios and Specifications 13.11.3 Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2025) 13.11.4 Spark Therapeutics Main Business Overview 13.11.5 Spark Therapeutics Latest Developments 13.12 Voyager Therapeutics 13.12.1 Voyager Therapeutics Company Information 13.12.2 Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product Portfolios and Specifications 13.12.3 Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2025) 13.12.4 Voyager Therapeutics Main Business Overview 13.12.5 Voyager Therapeutics Latest Developments 13.13 NightstaRx 13.13.1 NightstaRx Company Information 13.13.2 NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Product Portfolios and Specifications 13.13.3 NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Sales, Revenue, Price and Gross Margin (2020-2025) 13.13.4 NightstaRx Main Business Overview 13.13.5 NightstaRx Latest Developments 14 Research Findings and Conclusion
List of Tables Table 1. Adeno-Associated Virus Vectors in Gene Therapy Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions) Table 2. Adeno-Associated Virus Vectors in Gene Therapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions) Table 3. Major Players of Serotype 2 (AVV 2) Table 4. Major Players of Synthetic Serotypes Table 5. Major Players of Others Table 6. Global Adeno-Associated Virus Vectors in Gene Therapy Sales by Type (2020-2025) & (Kg) Table 7. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Type (2020-2025) Table 8. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Type (2020-2025) & ($ million) Table 9. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Type (2020-2025) Table 10. Global Adeno-Associated Virus Vectors in Gene Therapy Sale Price by Type (2020-2025) & (US$/Kg) Table 11. Global Adeno-Associated Virus Vectors in Gene Therapy Sale by Application (2020-2025) & (Kg) Table 12. Global Adeno-Associated Virus Vectors in Gene Therapy Sale Market Share by Application (2020-2025) Table 13. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Application (2020-2025) & ($ million) Table 14. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Application (2020-2025) Table 15. Global Adeno-Associated Virus Vectors in Gene Therapy Sale Price by Application (2020-2025) & (US$/Kg) Table 16. Global Adeno-Associated Virus Vectors in Gene Therapy Sales by Company (2020-2025) & (Kg) Table 17. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Company (2020-2025) Table 18. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Company (2020-2025) & ($ millions) Table 19. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Company (2020-2025) Table 20. Global Adeno-Associated Virus Vectors in Gene Therapy Sale Price by Company (2020-2025) & (US$/Kg) Table 21. Key Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Producing Area Distribution and Sales Area Table 22. Players Adeno-Associated Virus Vectors in Gene Therapy Products Offered Table 23. Adeno-Associated Virus Vectors in Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) Table 24. New Products and Potential Entrants Table 25. Market M&A Activity & Strategy Table 26. Global Adeno-Associated Virus Vectors in Gene Therapy Sales by Geographic Region (2020-2025) & (Kg) Table 27. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share Geographic Region (2020-2025) Table 28. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Geographic Region (2020-2025) & ($ millions) Table 29. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Geographic Region (2020-2025) Table 30. Global Adeno-Associated Virus Vectors in Gene Therapy Sales by Country/Region (2020-2025) & (Kg) Table 31. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Country/Region (2020-2025) Table 32. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Country/Region (2020-2025) & ($ millions) Table 33. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Country/Region (2020-2025) Table 34. Americas Adeno-Associated Virus Vectors in Gene Therapy Sales by Country (2020-2025) & (Kg) Table 35. Americas Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Country (2020-2025) Table 36. Americas Adeno-Associated Virus Vectors in Gene Therapy Revenue by Country (2020-2025) & ($ millions) Table 37. Americas Adeno-Associated Virus Vectors in Gene Therapy Sales by Type (2020-2025) & (Kg) Table 38. Americas Adeno-Associated Virus Vectors in Gene Therapy Sales by Application (2020-2025) & (Kg) Table 39. APAC Adeno-Associated Virus Vectors in Gene Therapy Sales by Region (2020-2025) & (Kg) Table 40. APAC Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Region (2020-2025) Table 41. APAC Adeno-Associated Virus Vectors in Gene Therapy Revenue by Region (2020-2025) & ($ millions) Table 42. APAC Adeno-Associated Virus Vectors in Gene Therapy Sales by Type (2020-2025) & (Kg) Table 43. APAC Adeno-Associated Virus Vectors in Gene Therapy Sales by Application (2020-2025) & (Kg) Table 44. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales by Country (2020-2025) & (Kg) Table 45. Europe Adeno-Associated Virus Vectors in Gene Therapy Revenue by Country (2020-2025) & ($ millions) Table 46. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales by Type (2020-2025) & (Kg) Table 47. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales by Application (2020-2025) & (Kg) Table 48. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales by Country (2020-2025) & (Kg) Table 49. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Country (2020-2025) Table 50. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales by Type (2020-2025) & (Kg) Table 51. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales by Application (2020-2025) & (Kg) Table 52. Key Market Drivers & Growth Opportunities of Adeno-Associated Virus Vectors in Gene Therapy Table 53. Key Market Challenges & Risks of Adeno-Associated Virus Vectors in Gene Therapy Table 54. Key Industry Trends of Adeno-Associated Virus Vectors in Gene Therapy Table 55. Adeno-Associated Virus Vectors in Gene Therapy Raw Material Table 56. Key Suppliers of Raw Materials Table 57. Adeno-Associated Virus Vectors in Gene Therapy Distributors List Table 58. Adeno-Associated Virus Vectors in Gene Therapy Customer List Table 59. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Forecast by Region (2026-2031) & (Kg) Table 60. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Forecast by Region (2026-2031) & ($ millions) Table 61. Americas Adeno-Associated Virus Vectors in Gene Therapy Sales Forecast by Country (2026-2031) & (Kg) Table 62. Americas Adeno-Associated Virus Vectors in Gene Therapy Annual Revenue Forecast by Country (2026-2031) & ($ millions) Table 63. APAC Adeno-Associated Virus Vectors in Gene Therapy Sales Forecast by Region (2026-2031) & (Kg) Table 64. APAC Adeno-Associated Virus Vectors in Gene Therapy Annual Revenue Forecast by Region (2026-2031) & ($ millions) Table 65. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Forecast by Country (2026-2031) & (Kg) Table 66. Europe Adeno-Associated Virus Vectors in Gene Therapy Revenue Forecast by Country (2026-2031) & ($ millions) Table 67. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Forecast by Country (2026-2031) & (Kg) Table 68. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Revenue Forecast by Country (2026-2031) & ($ millions) Table 69. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Forecast by Type (2026-2031) & (Kg) Table 70. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Forecast by Type (2026-2031) & ($ millions) Table 71. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Forecast by Application (2026-2031) & (Kg) Table 72. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Forecast by Application (2026-2031) & ($ millions) Table 73. Amicus Therapeutics Basic Information, Adeno-Associated Virus Vectors in Gene Therapy Manufacturing Base, Sales Area and Its Competitors Table 74. Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product Portfolios and Specifications Table 75. Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025) Table 76. Amicus Therapeutics Main Business Table 77. Amicus Therapeutics Latest Developments Table 78. Asklepios Biopharmaceutical Basic Information, Adeno-Associated Virus Vectors in Gene Therapy Manufacturing Base, Sales Area and Its Competitors Table 79. Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Product Portfolios and Specifications Table 80. Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025) Table 81. Asklepios Biopharmaceutical Main Business Table 82. Asklepios Biopharmaceutical Latest Developments Table 83. BioMarin Pharmaceutical Basic Information, Adeno-Associated Virus Vectors in Gene Therapy Manufacturing Base, Sales Area and Its Competitors Table 84. BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Product Portfolios and Specifications Table 85. BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025) Table 86. BioMarin Pharmaceutical Main Business Table 87. BioMarin Pharmaceutical Latest Developments Table 88. Coave Therapeutics Basic Information, Adeno-Associated Virus Vectors in Gene Therapy Manufacturing Base, Sales Area and Its Competitors Table 89. Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product Portfolios and Specifications Table 90. Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025) Table 91. Coave Therapeutics Main Business Table 92. Coave Therapeutics Latest Developments Table 93. MeiraGTx Basic Information, Adeno-Associated Virus Vectors in Gene Therapy Manufacturing Base, Sales Area and Its Competitors Table 94. MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Product Portfolios and Specifications Table 95. MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025) Table 96. MeiraGTx Main Business Table 97. MeiraGTx Latest Developments Table 98. Neurocrine Biosciences Basic Information, Adeno-Associated Virus Vectors in Gene Therapy Manufacturing Base, Sales Area and Its Competitors Table 99. Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Product Portfolios and Specifications Table 100. Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025) Table 101. Neurocrine Biosciences Main Business Table 102. Neurocrine Biosciences Latest Developments Table 103. Pfizer Basic Information, Adeno-Associated Virus Vectors in Gene Therapy Manufacturing Base, Sales Area and Its Competitors Table 104. Pfizer Adeno-Associated Virus Vectors in Gene Therapy Product Portfolios and Specifications Table 105. Pfizer Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025) Table 106. Pfizer Main Business Table 107. Pfizer Latest Developments Table 108. Roche Holding Basic Information, Adeno-Associated Virus Vectors in Gene Therapy Manufacturing Base, Sales Area and Its Competitors Table 109. Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Product Portfolios and Specifications Table 110. Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025) Table 111. Roche Holding Main Business Table 112. Roche Holding Latest Developments Table 113. Sangamo Therapeutics Basic Information, Adeno-Associated Virus Vectors in Gene Therapy Manufacturing Base, Sales Area and Its Competitors Table 114. Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product Portfolios and Specifications Table 115. Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025) Table 116. Sangamo Therapeutics Main Business Table 117. Sangamo Therapeutics Latest Developments Table 118. Sarepta Therapeutics Basic Information, Adeno-Associated Virus Vectors in Gene Therapy Manufacturing Base, Sales Area and Its Competitors Table 119. Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product Portfolios and Specifications Table 120. Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025) Table 121. Sarepta Therapeutics Main Business Table 122. Sarepta Therapeutics Latest Developments Table 123. Spark Therapeutics Basic Information, Adeno-Associated Virus Vectors in Gene Therapy Manufacturing Base, Sales Area and Its Competitors Table 124. Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product Portfolios and Specifications Table 125. Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025) Table 126. Spark Therapeutics Main Business Table 127. Spark Therapeutics Latest Developments Table 128. Voyager Therapeutics Basic Information, Adeno-Associated Virus Vectors in Gene Therapy Manufacturing Base, Sales Area and Its Competitors Table 129. Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product Portfolios and Specifications Table 130. Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025) Table 131. Voyager Therapeutics Main Business Table 132. Voyager Therapeutics Latest Developments Table 133. NightstaRx Basic Information, Adeno-Associated Virus Vectors in Gene Therapy Manufacturing Base, Sales Area and Its Competitors Table 134. NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Product Portfolios and Specifications Table 135. NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2025) Table 136. NightstaRx Main Business Table 137. NightstaRx Latest Developments List of Figures Figure 1. Picture of Adeno-Associated Virus Vectors in Gene Therapy Figure 2. Adeno-Associated Virus Vectors in Gene Therapy Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Growth Rate 2020-2031 (Kg) Figure 7. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth Rate 2020-2031 ($ millions) Figure 8. Adeno-Associated Virus Vectors in Gene Therapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions) Figure 9. Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Country/Region (2024) Figure 10. Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Country/Region (2020, 2024 & 2031) Figure 11. Product Picture of Serotype 2 (AVV 2) Figure 12. Product Picture of Synthetic Serotypes Figure 13. Product Picture of Others Figure 14. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Type in 2025 Figure 15. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Type (2020-2025) Figure 16. Adeno-Associated Virus Vectors in Gene Therapy Consumed in Alzheimer's Disease Figure 17. Global Adeno-Associated Virus Vectors in Gene Therapy Market: Alzheimer's Disease (2020-2025) & (Kg) Figure 18. Adeno-Associated Virus Vectors in Gene Therapy Consumed in Cystic Dibrosis Figure 19. Global Adeno-Associated Virus Vectors in Gene Therapy Market: Cystic Dibrosis (2020-2025) & (Kg) Figure 20. Adeno-Associated Virus Vectors in Gene Therapy Consumed in Hemophilia B Figure 21. Global Adeno-Associated Virus Vectors in Gene Therapy Market: Hemophilia B (2020-2025) & (Kg) Figure 22. Adeno-Associated Virus Vectors in Gene Therapy Consumed in Parkinson's Disease Figure 23. Global Adeno-Associated Virus Vectors in Gene Therapy Market: Parkinson's Disease (2020-2025) & (Kg) Figure 24. Global Adeno-Associated Virus Vectors in Gene Therapy Sale Market Share by Application (2024) Figure 25. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Application in 2025 Figure 26. Adeno-Associated Virus Vectors in Gene Therapy Sales by Company in 2025 (Kg) Figure 27. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Company in 2025 Figure 28. Adeno-Associated Virus Vectors in Gene Therapy Revenue by Company in 2025 ($ millions) Figure 29. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Company in 2025 Figure 30. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Geographic Region (2020-2025) Figure 31. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Geographic Region in 2025 Figure 32. Americas Adeno-Associated Virus Vectors in Gene Therapy Sales 2020-2025 (Kg) Figure 33. Americas Adeno-Associated Virus Vectors in Gene Therapy Revenue 2020-2025 ($ millions) Figure 34. APAC Adeno-Associated Virus Vectors in Gene Therapy Sales 2020-2025 (Kg) Figure 35. APAC Adeno-Associated Virus Vectors in Gene Therapy Revenue 2020-2025 ($ millions) Figure 36. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales 2020-2025 (Kg) Figure 37. Europe Adeno-Associated Virus Vectors in Gene Therapy Revenue 2020-2025 ($ millions) Figure 38. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales 2020-2025 (Kg) Figure 39. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Revenue 2020-2025 ($ millions) Figure 40. Americas Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Country in 2025 Figure 41. Americas Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Country (2020-2025) Figure 42. Americas Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Type (2020-2025) Figure 43. Americas Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Application (2020-2025) Figure 44. United States Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth 2020-2025 ($ millions) Figure 45. Canada Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth 2020-2025 ($ millions) Figure 46. Mexico Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth 2020-2025 ($ millions) Figure 47. Brazil Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth 2020-2025 ($ millions) Figure 48. APAC Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Region in 2025 Figure 49. APAC Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Region (2020-2025) Figure 50. APAC Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Type (2020-2025) Figure 51. APAC Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Application (2020-2025) Figure 52. China Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth 2020-2025 ($ millions) Figure 53. Japan Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth 2020-2025 ($ millions) Figure 54. South Korea Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth 2020-2025 ($ millions) Figure 55. Southeast Asia Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth 2020-2025 ($ millions) Figure 56. India Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth 2020-2025 ($ millions) Figure 57. Australia Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth 2020-2025 ($ millions) Figure 58. China Taiwan Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth 2020-2025 ($ millions) Figure 59. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Country in 2025 Figure 60. Europe Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Country (2020-2025) Figure 61. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Type (2020-2025) Figure 62. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Application (2020-2025) Figure 63. Germany Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth 2020-2025 ($ millions) Figure 64. France Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth 2020-2025 ($ millions) Figure 65. UK Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth 2020-2025 ($ millions) Figure 66. Italy Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth 2020-2025 ($ millions) Figure 67. Russia Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth 2020-2025 ($ millions) Figure 68. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Country (2020-2025) Figure 69. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Type (2020-2025) Figure 70. Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Application (2020-2025) Figure 71. Egypt Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth 2020-2025 ($ millions) Figure 72. South Africa Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth 2020-2025 ($ millions) Figure 73. Israel Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth 2020-2025 ($ millions) Figure 74. Turkey Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth 2020-2025 ($ millions) Figure 75. GCC Countries Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth 2020-2025 ($ millions) Figure 76. Manufacturing Cost Structure Analysis of Adeno-Associated Virus Vectors in Gene Therapy in 2025 Figure 77. Manufacturing Process Analysis of Adeno-Associated Virus Vectors in Gene Therapy Figure 78. Industry Chain Structure of Adeno-Associated Virus Vectors in Gene Therapy Figure 79. Channels of Distribution Figure 80. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Forecast by Region (2026-2031) Figure 81. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share Forecast by Region (2026-2031) Figure 82. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share Forecast by Type (2026-2031) Figure 83. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share Forecast by Type (2026-2031) Figure 84. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share Forecast by Application (2026-2031) Figure 85. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share Forecast by Application (2026-2031)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amicus Therapeutics|||Asklepios Biopharmaceutical|||BioMarin Pharmaceutical|||Coave Therapeutics|||MeiraGTx|||Neurocrine Biosciences|||Pfizer|||Roche Holding|||Sangamo Therapeutics|||Sarepta Therapeutics|||Spark Therapeutics|||Voyager Therapeutics|||NightstaRx